Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001214659-17-005550)

Filing Details

Accession Number:: 0001214659-17-005550
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2017-09-07 18:56:15
Reporting Period:: 2017-09-07

Accepted Time:: 2017-09-07 18:56:15
Original Submission Date:: 2017-09-07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1316175	Anthera Pharmaceuticals Inc	ANTH	Pharmaceutical Preparations (2834)	201852016

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1509643	Craig John Thompson	25801 Industrial Blvd Suite B Hayward CA 94545	President & Ceo	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-09-07	10,400	$1.43	11,298	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The Reporting Person acquired the shares in the open market at an average cost of $1.432. Shares have been adjusted to reflect the issuer's 1-for-8 reverse stock split effectuated on April 28, 2017. This is an amendment to correct two errors in the original form 4 filed on September 7, 2017.